Earnings Feed
Start Free
Home/Filings/4/0001209191-21-045640
4//SEC Filing

Urso David M 4

Accession 0001209191-21-045640

CIK 0001262104other
View on SEC.govCompany Profile

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 6:49 PM ET

Size

16.8 KB

Accession

0001209191-21-045640

Insider Transaction Report

Form 4
Period: 2021-07-01
MEI Pharma, Inc.MEIP
Urso David M
Sr. V.P. and General Counsel
Transactions
  • Tax Payment

    Common Stock

    2021-07-02$2.94/sh−24,825$72,986→ 49,281 total
  • Award

    Stock Option (Right to Buy)

    2021-07-01+600,000→ 600,000 total
    Exercise: $2.95Exp: 2031-07-01→ Common Stock (600,000 underlying)
Holdings

  • Stock Option (Right to Buy)

    Exercise: $1.57Exp: 2025-07-28→ Common Stock (127,500 underlying)
    127,500

  • Stock Option (Right to Buy)

    Exercise: $4.33Exp: 2028-06-22→ Common Stock (130,000 underlying)
    130,000

  • Stock Option (Right to Buy)

    Exercise: $2.52Exp: 2029-07-01→ Common Stock (350,000 underlying)
    350,000

  • Stock Option (Right to Buy)

    Exercise: $2.83Exp: 2027-07-06→ Common Stock (130,000 underlying)
    130,000

  • Stock Option (Right to Buy)

    Exercise: $1.36Exp: 2026-07-29→ Common Stock (130,000 underlying)
    130,000

  • Stock Option (Right to Buy)

    Exercise: $4.28Exp: 2028-07-12→ Common Stock (220,000 underlying)
    220,000

  • Stock Option (Right to Buy)

    Exercise: $3.49Exp: 2030-07-02→ Common Stock (525,000 underlying)
    525,000
Footnotes (7)
  • [F1]Represents the number of shares withheld by and surrendered to the Issuer on July 2, 2021, to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying restricted stock units.
  • [F2]One-quarter of such options shall vest on July 1, 2022, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2022.
  • [F3]All of such options are presently exercisable.
  • [F4]One-quarter of such options vested on June 22, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on June 22, 2019.
  • [F5]One-quarter of such options vested on July 12, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019.
  • [F6]One-quarter of such options vested on July 1, 2020 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020.
  • [F7]One-quarter of such options vested on July 2, 2021 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021.

Documents

1 file

Issuer

MEI Pharma, Inc.

CIK 0001262104

→
Entity typeother

Related Parties

1
  • filerCIK 0001604256

Filing Metadata

Form type
4
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 6:49 PM ET
Size
16.8 KB
View on SEC.gov